Annotation Detail for CNGA3

Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa04740 | Olfactory transduction |
Pathway ID | Pathway Name |
---|
200078 | Visual signal transduction: Cones |
Pathway ID | Pathway Name |
---|
P00028 | Heterotrimeric G-protein signaling pathway-rod outer segment phototransduction |
Desease Name |
---|
Achromatopsia-2 |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in increased expression of CNGA3 mRNA | increases expression | 20406850
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CNGA3 mRNA | affects expression | 16483693
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of CNGA3 mRNA | increases expression | 12832660
|
C025299 |
polyphenols |
polyphenols results in decreased expression of CNGA3 mRNA | decreases expression | 16293270
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:C536128 |
Achromatopsia 2 |
marker/mechanism |
|
| |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.19 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.58 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
4.11 | 16434500 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.57 | 19483382 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
1.79 | 16705839 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
3.03 | 6135515 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.12 | 19176532 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
2.72 | 16293270 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.58 | 18551238 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.57 | 18249437 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
4.45 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
4.45 | 19370779 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.90 | 12083418 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
3.19 | 19236843 20131406 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.76 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.55 | 19772884 16221962 19176532 18467677 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.58 | 20558911 |
MESH:D007249 |
Inflammation |
|
polyphenols |
3.23 | 16366677 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.87 | 16306350 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.32 | 16705839 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
2.85 | 16698588 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
4.81 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.81 | 20007298 15890375 16377806 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.77 | 6135515 2876784 2876786 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
4.07 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.27 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.25 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.49 | 7678174 18551238 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.11 | 17405874 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.88 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.83 | 16049721 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.55 | 19058328 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.79 | 18551238 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
5.97 | 17997062 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.41 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.95 | 10091137 |
Pathway ID |
Pathway Name |
---|
KEGG:04740 |
Olfactory transduction |